[{"source": "benzinga", "link": "https://www.benzinga.com/general/entertainment/22/03/25996832/netflix-gives-green-light-to-three-asia-pacific-series", "title": "Netflix Gives Green Light To Three Asia-Pacific Series", "date": "2022-03-04 13:21", "summary": "Netflix (NASDAQ: NFLX) is expanding its international content line-up with three new series from the Asia-Pacific market.", "tickers": ["DIS", "NFLX"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Netflix Gives Green Light To Three Asia-Pacific Series. Netflix (NASDAQ: NFLX) is expanding its international content line-up with three new series from the Asia-Pacific market.\"\n\nStock Prediction(s) for DIS, NFLX:", "Prediction": "Bank of America Corp (NYSE: BAC) will increase because Jason Snipe decided to buy in, and the financials have come under significant pressure.", "price_info": {"BAC": {"company": "", "ticker": "BAC", "move": "up", "prices": [40.78, 40.49]}}}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/25992791/check-out-what-whales-are-doing-with-wfc", "title": "Check Out What Whales Are Doing With WFC", "date": "2022-03-04 11:04", "summary": "Someone with a lot of money to spend has taken a bearish stance on Wells Fargo (NYSE:WFC).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.", "tickers": ["WFC"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Check Out What Whales Are Doing With WFC. Someone with a lot of money to spend has taken a bearish stance on Wells Fargo (NYSE:WFC).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.\"\n\nStock Prediction(s) for WFC:", "Prediction": "Bank of America Corp (NYSE: BAC) will increase because Jason Snipe decided to buy in, and the financials have come under significant pressure.", "price_info": {"BAC": {"company": "", "ticker": "BAC", "move": "up", "prices": [40.745, 40.565]}}}, {"source": "benzinga", "link": "https://www.benzinga.com/general/entertainment/22/03/25987594/behind-pro-wrestlings-hottest-startup-how-qt-marshall-is-helping-build-aews-future", "title": "Behind Pro Wrestling's Hottest Startup: How QT Marshall Is Helping Build AEW's Future", "date": "2022-03-04 18:11", "summary": "Michael Cuellari is living his dream profession. It just so happens that dream involves punching people and occasionally being bashed with a steel chair.", "tickers": ["SBGI", "T", "WWE"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Behind Pro Wrestling's Hottest Startup: How QT Marshall Is Helping Build AEW's Future. Michael Cuellari is living his dream profession. It just so happens that dream involves punching people and occasionally being bashed with a steel chair.\"\n\nStock Prediction(s) for SBGI, T, WWE:", "Prediction": "Bank of America Corp (NYSE: BAC) will increase because Jason Snipe decided to buy in, and the financials have come under significant pressure.", "price_info": {"BAC": {"company": "", "ticker": "BAC", "move": "up"}}}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/22/03/25992756/expert-ratings-for-bilibili", "title": "Expert Ratings For Bilibili", "date": "2022-03-04 11:01", "summary": "Bilibili (NASDAQ:BILI) has observed the following analyst ratings within the last quarter: ", "tickers": ["BILI"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Expert Ratings For Bilibili. Bilibili (NASDAQ:BILI) has observed the following analyst ratings within the last quarter: \"\n\nStock Prediction(s) for BILI:", "Prediction": "Bank of America Corp (NYSE: BAC) will increase because Jason Snipe decided to buy in, and the financials have come under significant pressure.", "price_info": {"BAC": {"company": "", "ticker": "BAC", "move": "up", "prices": [40.845, 40.62]}}}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/25993961/this-is-what-whales-are-betting-on-alibaba-group-holding", "title": "This Is What Whales Are Betting On Alibaba Group Holding", "date": "2022-03-04 11:31", "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Alibaba Group Holding.\nLooking at options history for Alibaba Group Holding (NYSE:BABA) we detected 68 strange trades.", "tickers": ["BABA"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"This Is What Whales Are Betting On Alibaba Group Holding. A whale with a lot of money to spend has taken a noticeably bearish stance on Alibaba Group Holding.\nLooking at options history for Alibaba Group Holding (NYSE:BABA) we detected 68 strange trades.\"\n\nStock Prediction(s) for BABA:", "Prediction": "Bank of America Corp (NYSE: BAC) will increase because Jason Snipe decided to buy in, and the financials have come under significant pressure.", "price_info": {"BAC": {"company": "", "ticker": "BAC", "move": "up", "prices": [40.83, 40.735]}}}, {"source": "benzinga", "link": "https://www.benzinga.com/news/dividends/22/03/25989563/occidental-petroleum-dividend-insights", "title": "Occidental Petroleum: Dividend Insights", "date": "2022-03-04 09:47", "summary": "Tuesday marks the last chance for investors to receive the next  dividend payout from Occidental Petroleum (NYSE:OXY). ", "tickers": ["OXY"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Occidental Petroleum: Dividend Insights. Tuesday marks the last chance for investors to receive the next  dividend payout from Occidental Petroleum (NYSE:OXY). \"\n\nStock Prediction(s) for OXY:", "Prediction": "Bank of America Corp (NYSE: BAC) will increase because Jason Snipe decided to buy in, and the financials have come under significant pressure.", "price_info": {"BAC": {"company": "", "ticker": "BAC", "move": "up", "prices": [41.0701, 40.88]}}}]